Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Changes in the free-energy landscape of p38α MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations.

Kuzmanic A, Sutto L, Saladino G, Nebreda AR, Gervasio FL, Orozco M.

Elife. 2017 Apr 26;6. pii: e22175. doi: 10.7554/eLife.22175.

2.

Molecular engineering of polymersome surface topology.

Ruiz-Pérez L, Messager L, Gaitzsch J, Joseph A, Sutto L, Gervasio FL, Battaglia G.

Sci Adv. 2016 Apr 15;2(4):e1500948. doi: 10.1126/sciadv.1500948. eCollection 2016 Apr.

3.

An Allosteric Cross-Talk Between the Activation Loop and the ATP Binding Site Regulates the Activation of Src Kinase.

Pucheta-Martínez E, Saladino G, Morando MA, Martinez-Torrecuadrada J, Lelli M, Sutto L, D'Amelio N, Gervasio FL.

Sci Rep. 2016 Apr 11;6:24235. doi: 10.1038/srep24235.

4.

From residue coevolution to protein conformational ensembles and functional dynamics.

Sutto L, Marsili S, Valencia A, Gervasio FL.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13567-72. doi: 10.1073/pnas.1508584112. Epub 2015 Oct 20.

5.

The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study.

Bunney TD, Wan S, Thiyagarajan N, Sutto L, Williams SV, Ashford P, Koss H, Knowles MA, Gervasio FL, Coveney PV, Katan M.

EBioMedicine. 2015 Mar 1;2(3):194-204.

6.

The effect of a widespread cancer-causing mutation on the inactive to active dynamics of the B-Raf kinase.

Marino KA, Sutto L, Gervasio FL.

J Am Chem Soc. 2015 Apr 29;137(16):5280-3. doi: 10.1021/jacs.5b01421. Epub 2015 Apr 17.

PMID:
25868080
7.

The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion.

Dölker N, Górna MW, Sutto L, Torralba AS, Superti-Furga G, Gervasio FL.

PLoS Comput Biol. 2014 Oct 9;10(10):e1003863. doi: 10.1371/journal.pcbi.1003863. eCollection 2014 Oct.

8.

Conformational Changes and Free Energies in a Proline Isomerase.

Papaleo E, Sutto L, Gervasio FL, Lindorff-Larsen K.

J Chem Theory Comput. 2014 Sep 9;10(9):4169-74. doi: 10.1021/ct500536r.

PMID:
26588555
9.

Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.

Sutto L, Gervasio FL.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10616-21. doi: 10.1073/pnas.1221953110. Epub 2013 Jun 10.

10.

From A to B: a ride in the free energy surfaces of protein G domains suggests how new folds arise.

Sutto L, Camilloni C.

J Chem Phys. 2012 May 14;136(18):185101. doi: 10.1063/1.4712029.

PMID:
22583310
11.

Equilibrium properties of realistic random heteropolymers and their relevance for globular and naturally unfolded proteins.

Tiana G, Sutto L.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Dec;84(6 Pt 1):061910. Epub 2011 Dec 12.

PMID:
22304119
12.

The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation.

Lovera S, Sutto L, Boubeva R, Scapozza L, Dölker N, Gervasio FL.

J Am Chem Soc. 2012 Feb 8;134(5):2496-9. doi: 10.1021/ja210751t. Epub 2012 Jan 30.

PMID:
22280319
13.

A Hybrid All-Atom Structure-Based Model for Protein Folding and Large Scale Conformational Transitions.

Sutto L, Mereu I, Gervasio FL.

J Chem Theory Comput. 2011 Dec 13;7(12):4208-17. doi: 10.1021/ct200547m. Epub 2011 Nov 7.

PMID:
26598361
14.

Lymphotactin: how a protein can adopt two folds.

Camilloni C, Sutto L.

J Chem Phys. 2009 Dec 28;131(24):245105. doi: 10.1063/1.3276284.

PMID:
20059117
15.

Identification of the folding inhibitors of hen-egg lysozyme: gathering the right tools.

Caldarini M, Sutto L, Camilloni C, Vasile F, Broglia RA, Tiana G.

Eur Biophys J. 2010 May;39(6):911-9. doi: 10.1007/s00249-009-0441-1. Epub 2009 Mar 27.

PMID:
19326112
16.

Early events in protein folding: Is there something more than hydrophobic burst?

Camilloni C, Sutto L, Provasi D, Tiana G, Broglia RA.

Protein Sci. 2008 Aug;17(8):1424-33. doi: 10.1110/ps.035105.108. Epub 2008 May 29.

17.

Consequences of localized frustration for the folding mechanism of the IM7 protein.

Sutto L, Lätzer J, Hegler JA, Ferreiro DU, Wolynes PG.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19825-30. Epub 2007 Dec 5.

18.

Low-throughput model design of protein folding inhibitors.

Broglia RA, Tiana G, Sutto L, Provasi D, Perelli V.

Proteins. 2007 May 1;67(2):469-78.

PMID:
17295323
19.

Sequence of events in folding mechanism: beyond the Gō model.

Sutto L, Tiana G, Broglia RA.

Protein Sci. 2006 Jul;15(7):1638-52.

20.

Design of HIV-1-PR inhibitors that do not create resistance: blocking the folding of single monomers.

Broglia RA, Tiana G, Sutto L, Provasi D, Simona F.

Protein Sci. 2005 Oct;14(10):2668-81.

21.

Design of amino acid sequences to fold into C(alpha)-model proteins.

Amatori A, Tiana G, Sutto L, Ferkinghoff-Borg J, Trovato A, Broglia RA.

J Chem Phys. 2005 Aug 1;123(5):054904.

PMID:
16108690

Supplemental Content

Support Center